vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Whitestone REIT (WSR). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $43.9M, roughly 1.1× Whitestone REIT). Whitestone REIT runs the higher net margin — 52.0% vs -4.8%, a 56.8% gap on every dollar of revenue. On growth, Whitestone REIT posted the faster year-over-year revenue change (7.5% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $50.5M). Over the past eight quarters, Whitestone REIT's revenue compounded faster (8.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Whitestone REIT is a publicly traded real estate investment trust that acquires, owns, manages and redevelops open-air community shopping centers, primarily located in high-growth metropolitan areas across the southwestern and southeastern United States. Its property portfolio is largely anchored by daily necessity, service-focused retail tenants that cater to regular local consumer demand.
IRWD vs WSR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $43.9M |
| Net Profit | $-2.3M | $22.8M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 53.0% |
| Net Margin | -4.8% | 52.0% |
| Revenue YoY | -47.3% | 7.5% |
| Net Profit YoY | -200.9% | 31.7% |
| EPS (diluted) | $0.01 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $43.9M | ||
| Q3 25 | $122.1M | $41.0M | ||
| Q2 25 | $85.2M | $37.9M | ||
| Q1 25 | $41.1M | $38.0M | ||
| Q4 24 | $90.5M | $40.8M | ||
| Q3 24 | $91.6M | $38.6M | ||
| Q2 24 | $94.4M | $37.6M | ||
| Q1 24 | $74.9M | $37.2M |
| Q4 25 | $-2.3M | $22.8M | ||
| Q3 25 | $40.1M | $18.3M | ||
| Q2 25 | $23.6M | $5.1M | ||
| Q1 25 | $-37.4M | $3.7M | ||
| Q4 24 | $2.3M | $17.3M | ||
| Q3 24 | $3.6M | $7.6M | ||
| Q2 24 | $-860.0K | $2.6M | ||
| Q1 24 | $-4.2M | $9.3M |
| Q4 25 | 14.3% | 53.0% | ||
| Q3 25 | 61.8% | 45.5% | ||
| Q2 25 | 53.2% | 13.8% | ||
| Q1 25 | -70.7% | 10.2% | ||
| Q4 24 | 34.8% | 43.3% | ||
| Q3 24 | 28.0% | 20.3% | ||
| Q2 24 | 26.5% | 7.2% | ||
| Q1 24 | 14.7% | 25.9% |
| Q4 25 | -4.8% | 52.0% | ||
| Q3 25 | 32.8% | 44.7% | ||
| Q2 25 | 27.7% | 13.3% | ||
| Q1 25 | -90.9% | 9.7% | ||
| Q4 24 | 2.5% | 42.5% | ||
| Q3 24 | 4.0% | 19.7% | ||
| Q2 24 | -0.9% | 6.9% | ||
| Q1 24 | -5.6% | 25.1% |
| Q4 25 | $0.01 | $0.43 | ||
| Q3 25 | $0.23 | $0.35 | ||
| Q2 25 | $0.14 | $0.10 | ||
| Q1 25 | $-0.23 | $0.07 | ||
| Q4 24 | $0.03 | $0.34 | ||
| Q3 24 | $0.02 | $0.15 | ||
| Q2 24 | $-0.01 | $0.05 | ||
| Q1 24 | $-0.03 | $0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $4.9M |
| Total DebtLower is stronger | — | $649.4M |
| Stockholders' EquityBook value | $-261.8M | $458.1M |
| Total Assets | $396.9M | $1.2B |
| Debt / EquityLower = less leverage | — | 1.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $4.9M | ||
| Q3 25 | $140.4M | $6.8M | ||
| Q2 25 | $92.9M | $5.3M | ||
| Q1 25 | $108.5M | $5.6M | ||
| Q4 24 | $88.6M | $5.2M | ||
| Q3 24 | $88.2M | $2.5M | ||
| Q2 24 | $105.5M | $3.2M | ||
| Q1 24 | $121.5M | $6.2M |
| Q4 25 | — | $649.4M | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | $632.5M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $458.1M | ||
| Q3 25 | $-264.2M | $439.5M | ||
| Q2 25 | $-308.2M | $427.5M | ||
| Q1 25 | $-334.1M | $431.0M | ||
| Q4 24 | $-301.3M | $438.2M | ||
| Q3 24 | $-311.3M | $419.5M | ||
| Q2 24 | $-321.7M | $418.3M | ||
| Q1 24 | $-330.5M | $421.6M |
| Q4 25 | $396.9M | $1.2B | ||
| Q3 25 | $396.1M | $1.1B | ||
| Q2 25 | $342.9M | $1.2B | ||
| Q1 25 | $327.2M | $1.1B | ||
| Q4 24 | $350.9M | $1.1B | ||
| Q3 24 | $389.5M | $1.1B | ||
| Q2 24 | $395.6M | $1.1B | ||
| Q1 24 | $438.8M | $1.1B |
| Q4 25 | — | 1.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $50.8M |
| Free Cash FlowOCF − Capex | $74.6M | $50.5M |
| FCF MarginFCF / Revenue | 156.3% | 114.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | — | 2.22× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $50.8M | ||
| Q3 25 | $47.6M | $18.0M | ||
| Q2 25 | $-15.1M | $13.8M | ||
| Q1 25 | $20.0M | $3.1M | ||
| Q4 24 | $15.2M | $58.2M | ||
| Q3 24 | $9.9M | $16.4M | ||
| Q2 24 | $33.5M | $12.3M | ||
| Q1 24 | $45.0M | $11.5M |
| Q4 25 | $74.6M | $50.5M | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | $58.0M | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | 114.9% | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | 142.1% | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 2.22× | ||
| Q3 25 | 1.19× | 0.98× | ||
| Q2 25 | -0.64× | 2.74× | ||
| Q1 25 | — | 0.83× | ||
| Q4 24 | 6.74× | 3.36× | ||
| Q3 24 | 2.71× | 2.15× | ||
| Q2 24 | — | 4.73× | ||
| Q1 24 | — | 1.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
